There is significant growth in the Endoscopy Devices Market due to the increasing focus of hospitals, ambulatory surgical centers, and specialty clinics on minimally invasive diagnosis and treatment across gastrointestinal, urology, and gynecology applications. The rising transition from reusable devices to single-use endoscopes, growing adoption of high-definition visualization systems, and expanding outpatient endoscopy services are reshaping the global procedural landscape.
The global Endoscopy Devices Market was valued at USD 61.94 Billion in 2025 and is expected to reach USD 105.90 Billion by 2035, growing at a CAGR of 5.51% during the forecast period 2026-2035. Several factors are responsible for driving growth in the Endoscopy Devices Market such as the increasing prevalence of gastrointestinal disorders, rising adoption of single-use endoscopes for infection control, growing demand for high-definition imaging systems, and expanding endoscopy service capacity across hospitals and ambulatory surgical centers.
Gain Actionable Intelligence on the Endoscopy Devices Market - Request a Sample Report

Key Players
Some of the major companies operating in the Endoscopy Devices Market are Olympus Corporation, Medtronic plc, Johnson & Johnson (Ethicon Endo-Surgery), Boston Scientific Corporation, Fujifilm Holdings Corporation, Stryker Corporation, Karl Storz SE & Co. KG, Smith & Nephew plc, Pentax Medical (Hoya Corporation), Ambu A/S, Conmed Corporation, B. Braun Melsungen AG, Richard Wolf GmbH, and others.
Strategic Developments & Industry Innovations
-
Olympus co-founded Swan Endo Surgical in July 2025 to develop endoluminal gastrointestinal robotics for minimally invasive surgeries.
-
Medtronic partnered with Dragonfly Endoscopy in February 2025 to introduce the Dragonfly™ system across U.S. clinical trails.
-
Ethicon (Johnson & Johnson) issued a correction in July 2025 for certain Endopath Echelon Vascular White Reload lots due to potential malfunctions.
Top Players Driving Innovation in the Endoscopy Devices Market:
1. Olympus Corporation: Leading Global Endoscopic Imaging Innovation

Olympus Corporation leads the global endoscopy devices market, with its endoscopes and visualization systems used in over 16.5 million procedures worldwide in 2025, strengthened by leadership in high-definition imaging and flexible single-use endoscopes. Through consistent R&D investment, physician education programs, and strategic acquisitions such as Swan Endo Surgical, Olympus continues to gain leadership in endoscopic diagnostic and treatment procedures.
2. Medtronic plc: Advancing AI-Enabled Endoscopic Visualization

Medtronic's endoscopy portfolio, including advanced visualization systems and endotherapy devices, was utilized in over 12.8 million procedures globally in 2025, with a leading focus on minimally invasive treatments and AI-enabled imaging. With a presence in over 75 countries and its new Dragonfly™ system partnership, Medtronic continues to enhance procedure efficiency and patient outcomes across GI, pulmonary, and urology devices.
3. Johnson & Johnson (Ethicon Endo-Surgery): Expanding Endotherapy Device Portfolio

Johnson & Johnson's Ethicon Endo-Surgery division achieved usage in over 10.7 million endoscopic procedures globally in 2025, leading with advanced endotherapy devices and high-definition visualization systems. Operating in 70 countries with extensive surgical training programs and hospital partnerships, the company continues to advance minimally invasive endoscopic tools designed to reduce procedure-related complications.
Advancing Minimally Invasive Care Through Innovation in the Endoscopy Devices Market
The Endoscopy Devices Market is likely to register consistent growth due to the adoption of single-use endoscopes, high-definition visualization systems, and minimally invasive techniques by hospitals and ambulatory surgical centers. The growth of the market will be driven by innovations in robotic endoscopic systems, advanced imaging technologies, and expanding outpatient procedure capacity.
Key players in the market include Olympus Corporation, Medtronic plc, and Johnson & Johnson. They have been driving innovation in the industry through advanced visualization platforms, disposable endoscope technologies, and physician training infrastructure. With healthcare providers becoming more concerned about infection control and procedural efficiency, endoscopy devices will continue to play an essential part in global minimally invasive diagnosis and treatment.